COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN PANAMA

被引：0
|
作者：
Ordonez, J. [1 ]
Ordonez, A. [1 ]
Hidalgo Godinez, J. [2 ]
Buitrago, R. [2 ]
机构：
[1] True Consulting, Medellin, Ant, Colombia
[2] AstraZeneca CAC, San Jose, Costa Rica
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE448
引用
收藏
页码：S422 / S423
页数：2
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN COLOMBIA
    Ordonez, J.
    Ordonez, A.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S360 - S361
  • [2] COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN COSTA RICA
    Ordonez, J.
    Guadamuz, R.
    Monge, O.
    Ordonez, A.
    Hidalgo Godinez, J.
    Buitrago, R.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S382 - S383
  • [3] COST-UTILITY ANALYSIS OF MEPOLIZUMAB VERSUS BENRALIZUMAB FOR SEVERE EOSINOPHILIC ASTHMA IN THE COLOMBIAN HEALTHCARE SYSTEM
    Rodriguez, E.
    Garcia Nuncira, C. Y.
    [J]. VALUE IN HEALTH, 2020, 23 : S350 - S350
  • [4] Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia
    Jefferson Antonio, Buendia
    Patino, Diana Guerrero
    Lopez Moreno, Melisa
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (02) : 299 - 305
  • [5] Benralizumab (Fasenra) for Severe Eosinophilic Asthma
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1541): : 33 - 35
  • [6] Cost-utility of tiotropium in patients with severe asthma
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2024, 22 (01)
  • [7] Cost-utility of azithromycin in patients with severe asthma
    Buendia, Jefferson Antonio
    Patino, Diana Guerrero
    Feliciano-Alfonso, John Edwin
    [J]. JOURNAL OF ASTHMA, 2022, 59 (10) : 2008 - 2015
  • [8] Cost-utility of tiotropium in patients with severe asthma
    Jefferson Antonio Buendía
    Diana Guerrero Patiño
    [J]. Cost Effectiveness and Resource Allocation, 22
  • [9] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    [J]. THORAX, 2021, 76 : A142 - A142
  • [10] Efficacy of Benralizumab in patients with severe eosinophilic asthma
    Soto Hurtado, E.
    Rodriguez Gallego, Y.
    Arzola Rodriguez, M.
    [J]. PNEUMOLOGIE, 2023, 77 : S25 - S26
12345